期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (3)
Immune thrombotic thrombocytopenic purpura (iTTP) is caused by severe deficiency of plasma ADAMTS13 (a disintegrin and metalloproteinase with a thromb......
期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (7)
Background Inpatients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) are at increased risk for venous thromboembolism (VTE)......
期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (9)
Collagen triggers coagulation via activation of factor (F) XII. In a platelet-rich environment, collagen can also trigger coagulation independently of......
期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (9)
Background The natural history of patients with hematologic cancer and venous thromboembolism (VTE) has not been consistently evaluated. We aimed to c......
期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (10)
Aims To evaluate the effectiveness and safety of apixaban versus rivaroxaban among patients with nonvalvular atrial fibrillation (NVAF) and type 2 dia......
期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (9)
Background Systemic lupus erythematosus (SLE) is a complex disease characterized by autoimmunity toward apoptotic cells, excessive amounts of circulat......
期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (3)
Background Thrombosis is a dynamic process, and a thrombus undergoes physical and biochemical changes that may alter its response to reperfusion thera......
期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (3)
Background In January 2021, the Dutch vaccination program against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was started. Clinical s......
期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (7)
Background The long-term risk of major bleeding after discontinuing anticoagulant therapy for a first unprovoked venous thromboembolism (VTE) is uncer......
期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (4)
Septic shock is the archetypal clinical setting in which extensive crosstalk between inflammation and coagulation dysregulates the latter. The main an......
期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (7)
Background The recommended dose of idarucizumab, the specific reversal agent for dabigatran etexilate, is 5 g. However, published data showed biochemi......
期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (8)
Aims The mechanisms of coronary thrombosis can influence prognosis after ST-elevation myocardial infarction (STEMI) and allow for different treatment ......
期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (10)
Hepatectomy-induced coagulation disturbances have been well studied over the past decade. Cumulative evidence supports the superiority of global coagu......
期刊： THROMBOSIS AND HAEMOSTASIS, 2022; 122 (9)
Background Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-related pneumonia is associated with venous and arterial thrombosis. Aim of th......
